Numab Therapeutics Appoints Rajesh Chopra as Chief Scientific Officer
Position
Chief Scientific Officer
Company
Numab Therapeutics
Description
Numab Therapeutics has appointed Rajesh Chopra, M.D., PhD, as Chief Scientific Officer. With nearly four decades of experience in oncology and immunology, Dr. Chopra will enhance the company's scientific leadership and advance its innovative pipeline.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Apimeds Pharmaceuticals Appoints Eric Sherb as Chief Financial Officer (October 1, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Pliant Therapeutics Appoints David Raben as Chief Medical Officer (September 30, 2026)
- Iovance Biotherapeutics Appoints Noah Berkowitz as Chief Medical Officer (October 2, 2026)
- Prothena Corporation Announces Resignation of Chief Development Officer (October 2, 2026)
- Altimmune Appoints Richard Menziuso as Vice President, Global Controller (September 29, 2026)
Who to call at Numab Therapeutics, and when
A new leader at Numab Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Numab Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Numab Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Numab Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Numab Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Numab Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.